GINGIVITIS INCREASES 9-FOLD RISK OF DYING FROM COVID-19

Reading time is 2 mins

.
.
GINGIVITIS INCREASES 9-FOLD RISK OF DYING FROM COVID-19

As the number of cases of the new type of corona virus in the world approaches 150 million, a new study by Canadian scientists found that gingivitis increases the risk of death from Covid-19 by 8.8 times. In addition, people suffering from gingivitis were 3.5 times more likely to be hospitalized due to Covid-19 and 4.5 times more likely to need a ventilator, it was noted.

Researchers at McGill University in Canada said they found a strong link between gingivitis (periodontitis), a common disease, and severe Covid-19. People with gingivitis are 8.8 times more likely to die from Covid-19, experts said, adding that oral hygiene can reduce the risk.

However, individuals suffering from gingivitis were 3.5 times more likely to be hospitalized due to Covid-19 and 4.5 times more likely to need a ventilator.

Professor of the McGill School of Dentistry, said: “looking at the results of our study reveals the importance of good oral health in the prevention and management of covid-19 complications. There is a very strong association between Periodontitis and the outcome of the disease,” he said.

.
GINGIVITIS (ABOUT PERIODONTITIS)

Gingivitis (periodontitis) can occur as a serious infection due to the accumulation of bacteria between the teeth and gums. If left untreated, it causes painful abscesses and tooth loss. In later cases, it damages the lower jaw bone.

Good oral hygiene, which includes brushing teeth twice daily, flossing and regular checkups, can prevent gingivitis, scientists say. “Periodontitis has been recognized as a risk factor for many diseases, both orally and systemic,” said, co-author of the study. If left untreated, this inflammation can spread throughout the body. The scientists also found links between the condition and heart disease, diabetes and respiratory diseases. There is also an association between gingivitis and the risk of miscarriage and increased pregnancy complications,” he said.

.
MORE THAN 500 PEOPLE WERE EXAMINED

The researchers used data from Hamad Medical Corporation, which includes nine hospitals in Qatar, as part of the study. In this context, the medical records of 568 patients were examined.

“In Qatar, medical and dental records have been digitized, which makes it possible to collect data and do this research quickly,” said. The study also assessed” various factors such as demographic, medical or mental health factors were taken into account.”

The study, on the other hand, found that biomarkers indicating inflammation were present at significantly higher levels in the blood of covid -19 patients who also had gingivitis.

.
GUM PATIENTS ALREADY HAVE HIGH LEVELS OF INFLAMMATION IN THEIR BODIES

“In the severe Covid-19 patients, the corona virus causes an inflammatory response that can lead to complications such as intubation and even death,” said. Our University research shows that periodontitis can exacerbate this,” he said.

The senior author of the study, Dr. “Gingivitis patients already get Covid-19 with high levels of inflammation in their bodies,” said. Covid-19 disease also causes hyperinflation in the body, which puts them at a disadvantage and makes them more susceptible to the severe consequences of the disease,” he concluded.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)